Praxis Precision Medicines
$29.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.41 (+1.39%) Today
$0.00 (0.00%) As of 11:00 AM UTC after-hours
Why Robinhood?
You can buy or sell PRAX and other stocks, options, and ETFs commission-free!
About PRAX
Praxis Precision Medicines, Inc. Common Stock, also called Praxis Precision Medicines, is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders.
CEO
Marcio Souza
Employees
67
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
1.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
138.19K
High Today
$30.41
Low Today
$28.82
Open Price
$29.44
Volume
150.64K
52 Week High
$60.79
52 Week Low
$23.90
PRAX Earnings
-$12.10
-$8.07
-$4.03
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market